FDA issued a Warning Letter to Shadow Holdings DBA Bocchi Labs on 2/6/2019 as a result of this inspection.
483 Shadow Holdings DBA Bocchi Labs Jun 2018

483 Shadow Holdings DBA Bocchi Labs Jun 2018

$119 - Not in Stock

FDA investigators audited the Shadow Holdings DBA Bocchi Labs - Santa Clarita, CA, United States facility and issued inspectional observations (via FDA 483) on 07 Jun 2018.

Product details

  • Category: Human Drugs / Foods & Cosmetics
  • Inspection end: 07 Jun 2018
  • Location: Santa Clarita, United States
  • FEI: 1000125317
Order